Diabetes care during the acute phase of infection in ICU patients with specific attention to COVID-19 outbreak

Anaesth Crit Care Pain Med. 2020 Jun;39(3):375-379. doi: 10.1016/j.accpm.2020.06.004. Epub 2020 Jun 17.

Authors

Bogdan Catargi¹, Gaëlle Cheisson², Igor Tauveron¹, Sophie Jacqueminet¹, Dan Benhamou³

Affiliations

¹ French Society for the study of Diabetes (SFD), 75009 Paris, France.
² French Society of Anaesthesia and Intensive Care (SFAR), 75016 Paris, France.
³ French Society of Anaesthesia and Intensive Care (SFAR), 75016 Paris, France. Electronic address: dan.benhamou@aphp.fr.

No abstract available

Publication types

Letter

MeSH terms

Acute Disease
Betacoronavirus*
Blood Glucose / analysis
COVID-19
Contraindications, Drug
Coronavirus Infections / complications*
Critical Care / methods
Critical Care / standards*
Diabetes Mellitus, Type 1 / complications
Diabetes Mellitus, Type 1 / drug therapy*
Diabetes Mellitus, Type 2 / complications
Diabetes Mellitus, Type 2 / drug therapy*
Diabetic Ketoacidosis / drug therapy
Diabetic Ketoacidosis / prevention & control
Drug Administration Routes
Glycated Hemoglobin / analysis
Humans
Hypoglycemic Agents / administration & dosage
Hypoglycemic Agents / adverse effects
Hypoglycemic Agents / therapeutic use
Insulin / administration & dosage
Insulin / therapeutic use
Insulin Resistance
Intensive Care Units
Pandemics*
Parenteral Nutrition
Pneumonia, Viral / complications*
Practice Guidelines as Topic*
SARS-CoV-2

Substances

Blood Glucose
Glycated Hemoglobin A
Hypoglycemic Agents
Insulin